Earnings Call · Q2 FY2022·2022-08-14

Q2 22EPS +18.18%·Rev n/aQ1 22EPS -14.75%·Rev n/aQ4 21EPS +1.64%·Rev n/aQ3 21EPS -56.13%·Rev n/a⚠ consensus missing

RELMADA THERAPEUTICS, INC. RLMD

+0.1%1d on move date−0.3% vs SPY3d−2.7%5d−0.3%

Research tier

Behavioral profile computed for this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RLMD calls or request research access.

More RLMD calls Browse calls Request research access